Post-ischemic inflammation regulates neural damage and protection

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Shichita, Takashi ^a,b   Ito, Minako ^a   Yoshimura, Akihiko ^a  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cytokines; Damage associated molecular patterns (DAMPs); Inflammasome; Inflammation; Resolution of inflammation

Indexed keywords

CD36 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL DNA; NEUROTROPHIC FACTOR; NUCLEIC ACID; NUCLEOTIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CELL ACTIVATION; CELL REGENERATION; CELLULAR IMMUNITY; GENE OVEREXPRESSION; HUMAN; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MACROPHAGE; NERVE INJURY; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NICK END LABELING; TISSUE REPAIR;

EID: 84907979748     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00319     Document Type: Article

References (103)

1. Abe, T., Shimamura, M., Jackman, K., Kurinami, H., Anrather, J., Zhou, P., et al. (2010). Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke 41, 898–904. doi: 10.1161/STROKEAHA.109.572552
2. Abulafia, D. P., de Rivero Vaccari, J. P., Lozano, J. D., Lotocki, G., Keane, R. W., and Dietrich, W. D. (2009). Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 29, 534–544. doi: 10.1038/jcbfm.2008.143
3. Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A., Martínez, C. M., Amores-Iniesta, J., Compan, V., et al. (2014). The NLRP3 inflammasomeisreleasedasaparticulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738–748. doi: 10.1038/ni.2919
4. Basta, G., Schmidt, A. M., and De Caterina, R. (2004). Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 63, 582–592. doi: 10.1016/j.cardiores.2004.05.001
5. Bazan, N. G. (2009). Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer’s disease. J. Lipid Res. 50, S400–S405. doi: 10.1194/jlr.R800068-JLR200
6. Bohacek, I., Cordeau, P., Lalancette-Hébert, M., Gorup, D., Weng, Y. C., Gajovic, S., et al. (2012). Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J. Neuroinflammation 9, 191. doi: 10.1186/1742-2094-9-191
7. Bonventre, J. V., Huang, Z., Taheri, M. R., O’Leary, E., Li, E., Moskowitz, M. A., et al. (1997). Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622–625. doi: 10.1038/37635
8. Brea, D., Sobrino, T., Rodríguez-Yáñez, M., Ramos-Cabrer, P., Agulla, J., Rodríguez-González, R., et al. (2011). Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin. Imunol. 139, 193–198. doi: 10.1016/j.clim.2011.02.001
9. Buckley, C. D., Gilroy, D. W., Serhan, C. N., Stockinger, B., and Tak, P. P. (2012). The resolution of inflammation. Nat. Rev. Immunol. 13, 59–66. doi: 10.1038/nri3362
10. Cai, W., Uribarri, J., Zhu, L., Chen, X., Swamy, S., Zhao, Z., et al. (2014). Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 111, 4940–4945. doi: 10.1073/pnas.1316013111
11. Calió, M. L., Marinho, D. S., Ko, G. M., Ribeiro, R. R., Carbonel, A. F., Oyama, L. M., et al. (2014). Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model. Free Radic. Biol. Med. 70, 141–154. doi: 10.1016/j.freeradbiomed.2014.01.024
12. Cekanaviciute, E., Fathali, N., Doyle, K. P., Williams, A. M., Han, J., and Buckwal-ter, M. S. (2014). Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia 62, 1227–1240. doi: 10.1002/glia.22675
13. Ceruti, S., Villa, G., Genovese, T., Mazzon, E., Longhi, R., Rosa, P., et al. (2009). The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain 132(Pt 8), 2206–2218. doi: 10.1093/brain/awp147
14. Chen, C. J., Kono, H., Golenbock, D., Reed, G., Akira, S., and Rock, K. L. (2007). Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851–856. doi: 10.1038/nm1603
15. Cho, S., Park, E. M., Febbraio, M., Anrather, J., Park, L., Racchumi, G., et al. (2005). The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 25, 2504–2512. doi: 10.1523/JNEUROSCI.0035-05.2005
16. Chun, K. H., and Seong, S. Y. (2010). CD14 but not MD2 transmit signals from DAMP. Int. Immunopharmaol. 10, 98–106. doi: 10.1016/j.intimp.2009.10.002
17. Clemens, J. A., Stephenson, D. T., Smalstig, E. B., Roberts, E. F., Johnstone, E. M., Sharp, J. D., et al. (1996). Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke 27, 527–535. doi: 10.1161/01.STR.27.3.527
18. Cuartero, M. I., Ballesteros, I., Moraga, A., Nombela, F., Vivancos, J., Hamilton, J. A., et al. (2013). N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARg agonist rosiglitazone. Stroke 44, 3498–3508. doi: 10.1161/STROKEAHA.113.002470
19. Denes, A., Wilkinson, F., Bigger, B., Chu, M., Rothwell, N. J., and Allan, S. M. (2013). Central and haematopoietic interleukin-1 both contribute to ischaemic brain injury. Dis. Model. Mech. 6, 1043–1048. doi: 10.1242/dmm.011601
20. Desestret, V., Riou, A., Chauveau, F., Cho, T. H., Devillard, E., Marinescu, M., et al. (2013). In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutics effects of M2 macrophages. PLoS ONE. 8:e67063. doi: 10.1371/journal.pone.0067063
21. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397. doi: 10.1016/S0166-2236(99)01401-0
22. Estévez, A. G., Sahawneh, M. A., Lange, P. S., Bae, N., Egea, M., and Ratan, R. R. (2006). Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons. J. Neurosci. 26, 8512–8516. doi: 10.1523/JNEUROSCI.0728-06.2006
23. Fann, D. Y., Lee, S. Y., Manzanero, S., Tang, S. C., Gelderblom, M., Chunduri, P., et al. (2013). Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 4, e790. doi: 10.1038/cddis.2013.326
24. Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., et al. (2014). The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat. Immunol. 15, 727–737. doi: 10.1038/ni.2913
25. 2 and its receptors. Nat. Rev. Endocrinol. 7, 163–175. doi: 10.1038/nrendo.2010.194
26. Gao, S., Zhang, R., Greenberg, M. E., Sun, M., Chen, X., Levison, B. S., et al. (2006). Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phos-pholipids lacking CD36 binding activity in vivo. J. Biol. Chem. 281, 31298–31308. doi: 10.1074/jbc.M604039200
27. Gorina, R., Lyck, R., Vestweber, D., and Engelhardt, B. (2014). β2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood–brain barrier. J. Immunol. 192, 324–337. doi: 10.4049/jimmunol.1300858
28. Gudi, V., Škuljec, J., Yildiz, Ö., Frichert, K., Skripuletz, T., Moharregh-Khiabani, D., et al. (2011). Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS ONE 6:e22623. doi: 10.1371/journal.pone.0022623
29. Guo, L., Ge, J., Wang, S., Zhou, Y., Wang, X., and Wu, Y. (2013). A novel method for efficient delivery of stem cells to the ischemic brain. Stem Cell Res. Ther. 4, 116. doi: 10.1186/scrt327
30. Guo, Z., Zhang, L., Wu, Z., Chen, Y., Wang, F., and Chen, G. (2014). In Vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. Cell Stem Cell 14, 188–202. doi: 10.1016/j.stem.2013.12.001
31. Haider, L., Fischer, M. T., Frishcer, J. M., Bauer, J., Höftberger, R., Botond, G., et al. (2011). Oxidative damage in multiple sclerosis lesions. Brain 134(Part 7), 1914–1924. doi: 10.1093/brain/awr128
32. Hill, J. J., Jin, K., Mao, X. O., Xie, L., and Greenberg, D. A. (2012). Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats. Proc. Natl. Acad. Sci. U.S.A. 109, 9155–9160. doi: 10.1073/pnas.1205697109
33. Ho, P. P., Kanter, J. L., Johnson, A. M., Srinagesh, H. K., Chang, E. J., Purdy, T. M., et al. (2012). Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci. Transl. Med. 4, 137-73. doi: 10.1126/scitranslmed.3003831
34. Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., et al. (2012). Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063–3070. doi: 10.1161/STROKEAHA.112.659656
35. Hyakkoku, K., Hamanaka, J., Tsuruma, K., Shimazawa, M., Tanaka, H., Uematsu, S., et al. (2010). Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258–267. doi: 10.1016/j.neuroscience.2010.08.054
36. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796–808. doi: 10.1038/nm.2399
37. Ikeda, N., Nonoguchi, N., Zhao, M. Z., Watanabe, T., Kajimoto, Y., Furutama, D., et al. (2005). Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 36, 2725–2730. doi: 10.1161/01.STR.0000190006.88896.d3
38. Ikeno, Y., Konno, N., Cheon, S. H., Bolchi, A., Ottonello, S., Kitamoto, K., et al. (2005). Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J. Biol. Chem. 280, 28044–28052. doi: 10.1074/jbc.M503343200
39. Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., et al. (2013). Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39, 311–323. doi: 10.1016/j.immuni.2013.08.001
40. Kalladka, D., and Muir, K. W. (2014). Brain repair: cell therapy in stroke. Stem Cells Cloning 7, 31–44.
41. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384. doi: 10.1038/ni.1863
42. Konoeda, F., Shichita, T., Yoshida, H., Sugiyama, Y., Muto, G., Hasegawa, E., et al. (2010). Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem. Biophys. Res. Commun. 402, 500–506. doi: 10.1016/j.bbrc.2010.10.058
43. Kooijman, R., Sarre, S., Michotte, Y., and De Keyser, J. (2009). Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke 40, e83–e88. doi: 10.1161/STROKEAHA.108.528356
44. Kuang, X., Wang, L. F., Yu, L., Li, Y. J., Wang, Y. N., He, Q., et al. (2014). Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic. Biol. Med. 71, 165–175. doi: 10.1016/j.freeradbiomed.2014.03.028
45. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., and Kriz, J. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596–2605. doi: 10.1523/JNEUROSCI.5360-06.2007
46. Lalancette-Hébert, M., Swarup, V., Beaulieu, J. M., Bohacek, I., Abdelhamid, E., Weng, Y. C., et al. (2012). Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J. Neurosci. 32, 10383–10395. doi: 10.1523/JNEUROSCI.1498-12.2012
47. Lecker, R. R., Soldner, F., Velasco, I., Gavin, D. K., Androutsellis-Theotokis, A., and McKay, R. D. (2007). Long-lasting regeneration after ischemia in the cerebral cortex. Stroke 38, 153–161. doi: 10.1161/01.STR.0000252156.65953.a9
48. Leung, P. Y., Stevens, S. L., Packard, A. E., Lessov, N. S., Yang, T., Conrad, V. K., et al. (2012). Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 43, 1383–1389. doi: 10.1161/STROKEAHA.111.641522
49. Liang, X., Lin, L., Woodling, N. S., Wang, Q., Anacker, C., Pan, T., et al. (2011). Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. J. Clin. Invest. 121, 4362–4371. doi: 10.1172/JCI46279
50. Lo, E. H. (2010). Degeneration and repair in central nervous system disease. Nat. Med. 16, 1205–1209. doi: 10.1038/nm.2226
51. + T cells. Nat. Med. 16, 713–717. doi: 10.1038/nm.2150
52. Mabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., et al. (2000). Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31, 1735–1743. doi: 10.1161/01.STR.31.7.1735
53. Maeda, A., and Fadeel, B. (2014). Mitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals. Cell Death Dis. 5, e1312. doi: 10.1038/cddis.2014.277
54. Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., et al. (2003). Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807–43817. doi: 10.1074/jbc.M305841200
55. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417–426. doi: 10.1016/S1097-2765(02)00599-3
56. Matt, U., Sharif, O., Martins, R., Furtner, T., Langeberg, L., Gawish, R., et al. (2013). WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J. Clin. Invest. 123, 3014–3024. doi: 10.1172/JCI60681
57. 2 EP2 receptor in cerebral ischemia. J. Neurosci. 24, 257–268. doi: 10.1523/JNEUROSCI.4485-03.2004
58. Meisel, C., and Meisel, A. (2011). Suppressing immunosuppression after stroke. N. Engl. J. Med. 365, 2134–2136. doi: 10.1056/NEJMcibr1112454
59. Miller, Y. I., Choi, S. H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., et al. (2011). Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235-248. doi: 10.1161/CIRCRESAHA.110.223875
60. Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., et al. (1993). beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 92, 1243-1252. doi: 10.1172/JCI116696
61. Moskowitz, M. A., Lo, E. H., and Iadecola, C. (2010). The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198. doi: 10.1016/j.neuron.2010.07.002
62. Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., et al. (2008). The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 28,12023-12031. doi: 10.1523/JNEUROSCI.2435-08.2008
63. Muralikrishna Adibhatla, R., and Hatcher, J. F. (2006). Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40, 376-387. doi: 10.1016/j.freeradbiomed.2005.08.044
64. + oligodendrocyte progenitors. Glia 46, 183-194. doi: 10.1002/glia.10360
65. Ooboshi, H., Ibayashi, S., Shichita, T., Kumai, Y., Takada, J., Ago, T., et al. (2006). Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111, 913-919. doi: 10.1161/01.CIR.0000155622.68580.DC
66. Pál, G., Vincze, C., Renner, É., Wappler, E. A., Nagy, Z., Lovas, G., et al. (2012). Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain. PLoS ONE 7:e46731. doi: 10.1371/journal.pone.0046731
67. Qiang, X., Yang, W. L., Wu, R., Zhou, M., Jacob, A., Dong, W., et al. (2013). Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat. Med. 19,1489-1495. doi: 10.1038/nm.3368
68. Qiu, J., Nishimura, M., Wang, Y, Sims, J. R., Qiu, S., Savitz, S. I., et al. (2008). Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Me tab. 28, 927-938. doi: 10.1038/sj.jcbfm.9600582
69. Qu, W S., Wang, Y. H., Ma, J. F., Tian, D. S., Zhang, Q., Pan, D. J., et al. (2011). Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia. J. Neurochem. 116, 217-226. doi: 10.1111/j.1471-4159.2010.07095.x
70. Quintá, H. R., Pasquini, J. M., Rabinovich, G. A., and Pasquini, L. A. (2014). Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury. CellDeath. Differ. 21, 941-955. doi: 10.1038/cdd.2014.14
71. Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., and Landreth, G. E. (2009). CD14 and toll-like receptors 2 and 4 are required for fibrillar A|3-stimulated microglial activation. J. Neurosci. 29,11982-11992. doi: 10.1523/JNEUROSCI.3158-09.2009
72. Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101. doi: 10.1038/nature13479
73. Shanta, S. R., Choi, C. S., Lee, J. H., Shin, C. Y, Kim, Y J., Kim, K. H., et al. (2012). Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemia. J. Lipid Res. 53, 1823-1831. doi: 10.1194/jlr.M022558
74. Shichita, T., Hasegawa, E., Kimura, A., Morita, R., Sakaguchi, R., Takada, I., et al. (2012). Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 18, 911-917. doi: 10.1038/nm.2749
75. Shichita, T., Sugiyama, Y, Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., et al. (2009). Pivotal role of cerebral interleukin-17-producingy ST cells in the delayed phase of ischemic brain injury. Nat. Med. 215, 946-950. doi: 10.1038/nm.1999
76. + macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J. Cereb. Blood Flow Metab. 30, 603-615. doi: 10.1038/jcbfm.2009.233
77. Spohr, T. C, Dezonne, R. S., Rehen, S. K., and Gomes, F. C. (2011). Astrocytes treated by lysophosphatidic acid induce axonal outgrowth of cortical progenitors through extracellular matrix protein and epidermal growth factor signaling pathway. J. Neurochem. 119, 113-123. doi: 10.1111/j.1471-4159.2011.07421.x
78. Starossom, S. C, Mascanfroni, I. D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S. F., et al. (2012). Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37,249-263. doi: 10.1016/j.immuni.2012.05.023
79. Stevens, S. L., Leung, P. Y., Vartanian, K. B., Gopalan, B., Yang, T., Simon, R. P., et al. (2011). Multiple preconditioning paradigms converge on inter-feron regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J. Neurosci. 31, 8456–8463. doi: 10.1523/JNEUROSCI.0821-11.2011
80. Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., et al. (2010). CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155–161. doi: 10.1038/ni.1836
81. Sun, S., Sursal, T., Adibnia, Y., Zhao, C., Zheng, Y., Li, H., et al. (2013). Mitochon-drial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS ONE 8:e59989. doi: 10.1371/journal.pone.0059989
82. Suzuki, Y., Hattori, K., Hamanaka, J., Murase, T., Egashira, Y., Mishiro, K., et al. (2012). Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia. Sci. Rep. 2, 896. doi: 10.1038/srep00896
83. Suzuki, Y., Nakano, Y., Mishiro, K., Takagi, T., Tsuruma, K., Nakamura, M., et al. (2013). Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci. Rep. 3, 3177. doi: 10.1038/srep03177
84. Takeuchi, M., Yanase, Y., Matsuura, N., Yamagishi Si, S., Kameda, Y., Bucala, R., et al. (2001). Immunological detection of a novel advanced glycation end-product. Mol. Med. 7, 783–791.
85. Tang, S. C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., et al. (2007). Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U.S.A. 104, 13798–13803. doi: 10.1073/pnas.0702553104
86. Taniguchi, H., Anacker, C., Suarez-Mier, G. B., Wang, Q., and Andreasson, K. (2011). Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy. Neurosci. Lett. 504, 185–190. doi: 10.1016/j.neulet.2011.09.005
87. Tsai, S. Y., Segovia, J. A., Chang, T. H., Morris, I. R., Berton, M. T., Tessier, P. A., et al. (2014). DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog. 10:e1003848. doi: 10.1371/journal.ppat.1003848
88. Uchida, K. (2013). Redox-derived damage-associated molecular patterns: lig-and function of lipid peroxidation adducts. Redox Biol. 1, 94–96. doi: 10.1016/j.redox.2012.12.005
89. Walko, T. D.III, Bola, R. A., Hong, J. D., Au, A. K., Bell, M. J., Kochanek, P. M., et al. (2014). Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury. Shock 41, 499–503. doi: 10.1097/SHK.0000000000000160
90. Wei, Y., Yemisci, M., Kim, H. H., Yung, L. M., Shin, H. K., Hwang, S. K., et al. (2011). Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 69, 119–129. doi: 10.1002/ana.22186
91. Weil, Z. M. (2012). Ischemia-induced hyperglycemia: consequences, neuroen-docrine regulation, and a role for RAGE. Horm. Behav. 62, 280–285. doi: 10.1016/j.yhbeh.2012.04.001
92. Wenceslau, C. F., McCarthy, C. G., Szasz, T., Spitler, K., Goulopoulou, S., Webb, R. C., et al. (2014). Mitochondrial damage-associated molecular patterns and vascular function. Eur. Heart J. 35, 1172–1177. doi: 10.1093/eurheartj/ehu047
93. West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M., Kerr, B. A., Borden, E. C., et al. (2010). Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972–976. doi: 10.1038/nature09421
94. Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura, T., Negishi, H., et al. (2009). HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99–103. doi: 10.1038/nature08512
95. Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., et al. (2014). NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J. Cereb. Blood Flow Metab. 34, 660–667. doi: 10.1038/jcbfm.2013.242
96. Yang, Y., Liu, B., Dai, J., Srivastava, P. K., Zammit, D. J., Lefrançois, L., et al. (2007). Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26, 215–226. doi: 10.1016/j.immuni.2006.12.005
97. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., and Karin, N. (1992). Prevention of experimental autoimmune encephalomyeli-tis by antibodies against α4β1 integrin. Nature 356, 63–66. doi: 10.1038/356063a0
98. Zhang, J., Takahashi, H. K., Liu, K., Wake, H., Liu, R., Maruo, T., et al. (2011). Anti-high mobility group box-1 monoclonal antibody protects the blood–brain barrier from ischemia-induced disruption in rats. Stroke 42, 1420–1428. doi: 10.1161/STROKEAHA.110.598334
99. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107. doi: 10.1038/nature08780
100. Zhong, Z., Zhai, Y., Liang, S., Mori, Y., Han, R., Sutterwala, F. S., et al. (2013). TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun. 4, 1611. doi: 10.1038/ncomms2608
101. Zhu, W., Fan, Y., Frenzel, T., Gasmi, M., Bartus, R. T., Young, W. L., et al. (2008). Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 39, 1254–1261. doi: 10.1161/STROKEAHA.107.500801
102. Zhu, W., Fan, Y., Hao, Q., Shen, F., Hashimoto, T., Yang, G. Y., et al. (2009). Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke. J. Cereb. Blood Flow Metab. 29, 1528–1537. doi: 10.1038/jcbfm.2009.75
103. Ziegler, G., Freyer, D., Harhausen, D., Khojasteh, U., Nietfeld, W., and Trende-lenburg, G. (2011). Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke. J. Cereb. Blood Flow Metab. 31, 757–766. doi: 10.1038/jcbfm.2010.161